Jelena S Rasic Ozegovic

Mrs. Jelena S Rasic Ozegovic

Anti-Doping Agency of Serbia, Belgrade, Beograd, Serbia

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2017 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
ASA. Stajić
A. Stajić
MAM. Anđelković
M. Anđelković
NDN. Dikić
N. Dikić
Jelena S Rasic OzegovicJelena S Rasic Ozegovic
Jelena S Rasic Ozegovic
MVM. Vukašinović-Vesić
M. Vukašinović-Vesić
BJB. Jančić-Stojanović
B. Jančić-Stojanović

15 February 2024 in Journal of Chromatography B
Verified
Journal Article
Open access
BSB. Stojanovic
B. Stojanovic
Jelena S Rasic OzegovicJelena S Rasic Ozegovic
Jelena S Rasic Ozegovic
MAM. Andjelkovic
M. Andjelkovic
NDN. Dikic
N. Dikic
NDN. Dragicevic
N. Dragicevic
GGG. Gmeiner
G. Gmeiner
In 2017, higenamine was added to the World Antidoping Agency's (WADA) Prohibited list under group S3: beta-2 agonists and it is banned for athletes both in - and out of competition. Aim of this study was to characterize the urinary excretion profile of higenamine and its metabolite coclaurine after oral administration of multiple doses of higenamine capsules. For this purpose, an administration study including female basketball players was performed. For the detection of higenamine and cocalurine in the collected urine samples, a new, fast, and highly sensitive quantitative on-line SPE LC HRMS method was developed and validated. The method was applied for the quantification of higenamine and cocalurine in urine and their excretion pattern was defined. Results obtained show substantial inter-individual differences in the excretion profile of higenamine and coclaurine. For higenamine, half-lives were estimated to be between 4 and 27 h, and for coclaurine between 5 and 25 h. Furthermore, the data indicate that the elimination of coclaurine is rate-limited by its formation. Higenamine could be detected at a urine concentration above 10 ng/mL for at least 20 h after the last application for all study participants.

7 September 2021 in Frontiers in Psychology
Verified
Journal Article
Open access
Jelena S Rasic OzegovicJelena S Rasic Ozegovic
Jelena S Rasic Ozegovic
NINevena Ivanovic
Nevena Ivanovic
MAMarija Andjelkovic
Marija Andjelkovic
INIvana P Nedeljkovic
Ivana P Nedeljkovic
INIvan Nikolic
Ivan Nikolic
NDNenad Dikic
Nenad Dikic
The aim of this study was to determine the ergogenic effects and the safety profile of a one-component higenamine supplement in female recreational athletes. Twelve recreational female basketball players (age 29–41 years, oxygen consumption (VO2max) > 30 ml⋅kg–1⋅min–1, with training > 5 h wk–1) were randomized either to the higenamine group, or to the placebo group for 3 weeks. In order to determine ergogenic effects and safety profile of higenamine administration, we assessed the following variables before and after 3 weeks of supplementation: anthropometric parameters, resting metabolic rate (RMR), exercise testing variables, serum free fatty acids (FFAs), blood pressure, enzyme activity, urea, lipid profile, and complete blood count. There were no differences between groups in anthropometric parameters, including basal metabolic rate (BMR), RMR and body fat [p = 0.706 (Cohen’s d 0.223), p = 0.169 (Cohen’s d 0.857), and p = 0.223 (Cohen’s d 0.750), respectively], FFAs [0.43 ± 0.03 vs. 0.54 ± 0.23, p = 0.206 (Cohen’s d 0.540)], neither significant differences in cardiopulmonary parameters after the intervention period. Furthermore, all measured outcome variables in the safety assessment were not significant, with values remaining stable during the intervention period for participants in both groups. This is the first study to document the effects and the safety profile of higenamine-based dietary supplements at a specified dose in female recreational athletes. Our data indicate that 21-day of supplementation with 75 mg higenamine would not result in improving cardiopulmonary exercise fitness and weight loss in female recreational athletes. Moreover, supplementation with 75 mg higenamine is safe and well-tolerated in younger recreational female athletes.

6 August 2025 in Frontiers in Public Health
Verified
Journal Article
Open access
PDF file
ZVZoran Vesic
Zoran Vesic
JSJelena Stojicevic
Jelena Stojicevic
Nemanja RancicNemanja Rancic
Nemanja Rancic
GMGorica Milovanovic
Gorica Milovanovic
Jelena S Rasic OzegovicJelena S Rasic Ozegovic
Jelena S Rasic Ozegovic
MVMilica Vukasinovic Vesic
Milica Vukasinovic Vesic
Objectives: The aim of this study was to examine the impact of anti-doping education among professional athletes on anti-doping knowledge.Methods: A prospective cohort study was conducted on differences in knowledge toward doping among 404 professional athletes in relation to their education about doping.Results: Participants who underwent education answered correctly significantly more often on most of the questions compared to participants without education [difference of about 20–30% in the rate of correct answers is in favor of participants with education on every question; 8.49 (SD 2.75) vs. 11.04 (SD 1.89); p < 0.001]. The majority of participants in the group with prior education against doping answered 10 or more questions correctly out of a total of 13, while the group without prior education against doping most commonly had 7 to 11 correct answers (p < 0.001). The most significant predictors of correct answers are gender, number of years of training, type of sport (individual or team sport), and prior education about doping. The largest contribution to this model comes from the variable “prior education against doping,” followed by the type of sport.Conclusion: Our research shows that prior anti-doping education is effective and has the essential contribution on athletes’ knowledge about doping.

4 December 2025 in Sports
Verified
Journal Article
Open access
PDF file
GMGorica Milovanovic
Gorica Milovanovic
Jelena S Rasic OzegovicJelena S Rasic Ozegovic
Jelena S Rasic Ozegovic
DJDejan Jovicic
Dejan Jovicic
Nenad RadivojevicNenad Radivojevic
Nenad Radivojevic
Nemanja RancicNemanja Rancic
Nemanja Rancic
MVMilica Vukasinovic Vesic
Milica Vukasinovic Vesic
Background: Gender differences in anti-doping rule violations (ADRVs) have been noted in international research, yet systematic analyses are rare. This study addresses that gap by providing the first comprehensive evaluation of the doping prevalence by gender in Serbia. Methods: A 19-year retrospective quantitative analysis was conducted on data collected by the Anti-Doping Agency of Serbia (ADAS) between 2006 and 2024. In total, 14,919 doping controls were performed, including 10,912 (73.11%) on male athletes and 4007 (26.89%) on female athletes. Results: Across this period, 146 ADRVs were identified, with a clear gender imbalance: 128 (87.32%) cases involved male athletes and 18 (12.68%) female athletes. A Chi-Square test confirmed a significant association between gender and ADRVs, χ2(1, N = 14,919) = 15.11, p < 0.001, indicating that male athletes were more likely to violate anti-doping rules. Substance profiles also differed: anabolic agents (S1) dominated overall, while stimulants (S6) and cannabinoids (S8) were more frequent in males, and diuretics (S5) and hormone modulators (S4) in females. Conclusions: These findings reveal a pronounced gender disparity in doping behavior and substance choice, providing a foundation for further research and emphasizing the need for gender-sensitive anti-doping education and policy.

4 February 2024 in Proceedings
Verified
Conference Paper
Open access
PDF file
Jelena S Rasic OzegovicJelena S Rasic Ozegovic
Jelena S Rasic Ozegovic
MTMarija Takic
Marija Takic
NINevena Ivanovic
Nevena Ivanovic
Danijela Ristic-MedicDanijela Ristic-Medic
Danijela Ristic-Medic
MVMilica Vukasinovic Vesic
Milica Vukasinovic Vesic
BDBrizita ivan Djordjevic
Brizita ivan Djordjevic
Background and objectives: Higenamine is an alkaloid found in different plant species like Aconitum japonica, Nandina domestica, Gnetum parvifolium, and Asarum heterotropoides. According to the available data in the literature, its dietary intake leads to an enhancement of lipolysis. The objective of this study was to explore whether the ingestion of a one-component higenamine supplement (75 mg/day) for three weeks would introduce some changes in the fatty acid (FA) profiles of serum phospholipids of female recreational athletes. Methods: A total of 12 female recreational athletes were included in a double-blind study, with six participants in both groups—a higenamine treatment group and placebo group. Serum phospholipids were isolated via one-dimensional thin-layer chromatography. Fatty acid methyl ester samples from the phospholipids were analyzed by a gas–liquid chromatography method. Desaturase and elongase activities were calculated from product/precursor FA ratios. Results: In the group that was undergoing higenamine treatment, a statistically significant increase in the levels of linolenic acid, a total n − 6 polyunsaturated FAs (PUFAs), and an n − 6/n − 3 FA ratio were observed. But saturated palmitic acid and monounsaturated palmitoleic and oleic acid, as well as consequent total saturated FAs and monounsaturated FA acids decreased in serum phospholipids. Also, after 3 weeks of higenamine supplementation, arachidonic n − 6 acid and docosapentaenoic n − 3 acids levels were significantly decreased, and estimated delta-5 desaturase activity (arachidonic/dihomo-gamma-linolenic acid ratio) was decreased too. In the placebo group, a significant change was increased levels of oleic acid compared to baseline levels. Conclusion: According to the results obtained for the FA status of serum phospholipids, treatment with higenamine was followed by a modulation of serum phospholipid FA profiles. Furthermore, this could influence the desaturation/elongation metabolic pathway of endogenous FA metabolisms, leading to a decrease in delta-5 desaturase activity and consequently lower levels of long-chain PUFAs. For further discussion, it is necessary to assess the dietary intake of study participants.